Edition:
United Kingdom

Ligand Pharmaceuticals Inc (LGND.OQ)

LGND.OQ on NASDAQ Stock Exchange Global Market

114.29USD
9:00pm BST
Change (% chg)

$2.91 (+2.61%)
Prev Close
$111.38
Open
$112.63
Day's High
$114.81
Day's Low
$111.59
Volume
145,402
Avg. Vol
151,299
52-wk High
$277.48
52-wk Low
$98.56

About

Ligand Pharmaceuticals Incorporated (Ligand) is a biopharmaceutical company that focuses on developing and acquiring technologies that help pharmaceutical companies discover and develop medicines. The Company is involved in the development and licensing of biopharmaceutical assets. The Company employs research technologies, such... (more)

Overall

Beta: 1.40
Market Cap(Mil.): $2,182.87
Shares Outstanding(Mil.): 19.60
Dividend: --
Yield (%): --

Financials

  LGND.OQ Industry Sector
P/E (TTM): 3.17 103.73 36.81
EPS (TTM): 35.15 -- --
ROI: 68.46 7.70 12.05
ROE: 97.01 8.20 16.96

REFILE-BRIEF-Ligand Pharma - Entered A Worldwide Commercial Platform License Agreement With Genagon Therapeutics AB

* LIGAND PHARMACEUTICALS INC - ON FEB 4 ENTERED INTO A WORLDWIDE COMMERCIAL PLATFORM LICENSE AGREEMENT WITH GENAGON THERAPEUTICS AB

07 Feb 2019

Earnings vs. Estimates